Phase I/II Study of CAR.70- Engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Relapse/Refractory Hematological Malignances
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Ohio State University Comprehensive Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Southern California
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Icahn School of Medicine at Mount Sinai
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Indiana University
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
University of Nebraska
The First Affiliated Hospital with Nanjing Medical University
H. Lee Moffitt Cancer Center and Research Institute
M.D. Anderson Cancer Center
H. Lee Moffitt Cancer Center and Research Institute
Groupe Francophone des Myelodysplasies
M.D. Anderson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Alliance for Clinical Trials in Oncology
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
OHSU Knight Cancer Institute
University of Utah
Fred Hutchinson Cancer Center
M.D. Anderson Cancer Center
Memorial Sloan Kettering Cancer Center
Arbeitsgemeinschaft medikamentoese Tumortherapie
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Asan Medical Center
M.D. Anderson Cancer Center
Northwestern University
UNC Lineberger Comprehensive Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center